AEterna Zentaris AEZS 1000% Chance !? (Seite 776)
eröffnet am 21.11.15 14:39:40 von
neuester Beitrag 18.04.23 19:48:47 von
neuester Beitrag 18.04.23 19:48:47 von
Beiträge: 9.063
ID: 1.221.897
ID: 1.221.897
Aufrufe heute: 0
Gesamt: 1.452.413
Gesamt: 1.452.413
Aktive User: 0
ISIN: CA0079755017 · WKN: A3DMG4 · Symbol: AEZS
1,9900
USD
+0,51 %
+0,0100 USD
Letzter Kurs 25.04.24 Nasdaq
Neuigkeiten
Werte aus der Branche Biotechnologie
Wertpapier | Kurs | Perf. % |
---|---|---|
3,2800 | +60,78 | |
1,9000 | +59,66 | |
6,8000 | +36,00 | |
4,7450 | +35,57 | |
0,5250 | +19,08 |
Wertpapier | Kurs | Perf. % |
---|---|---|
1,7000 | -13,71 | |
3,0400 | -19,95 | |
1,9500 | -25,14 | |
1,6052 | -30,21 | |
0,5121 | -30,80 |
Beitrag zu dieser Diskussion schreiben
Antwort auf Beitrag Nr.: 51.332.229 von linkshaender am 18.12.15 11:50:50Hier der Link zum Artikel von Daniel Ward vom 18.5.2015. An den beiden Folgetagen gab es bereits einen Kurssturz um 30%.
http://seekingalpha.com/article/3191416-deteriorating-capita…
Ist allerdings archiviert.
http://seekingalpha.com/article/3191416-deteriorating-capita…
Ist allerdings archiviert.
Antwort auf Beitrag Nr.: 51.332.217 von linkshaender am 18.12.15 11:49:25Im verlinkten Dokument ist das Zitat auf Seite S-40
Antwort auf Beitrag Nr.: 51.330.774 von jhackel am 18.12.15 08:55:52Bin bei weitem kein Vollprofi, allerdings war die Toxic schon sehr bald klar als im alten Forum das "alternate cashless exercise" erwähnt wurde. Wurde zu dem Zeitpunkt auch sehr deutlich in einem SA-Artikel thematisiert. Link habe ich leider nicht mehr, kann man aber mehrfach im alten AEZS-Thread finden. Ist aber inzwischen bei SA archiviert.
Hier die entscheidende Textpassage zu den B-Warrants:
If, on any calendar day occurring on or after May 26, 2015 (or such earlier date that the Company or any of its subsidiaries, on a consolidated basis, have spent an aggregate of $4 million, in cash or cash equivalents outside of the ordinary course of business after the original Subscription Date, including, without limitation, payments in connection with acquisitions, strategic partnerships, acquisitions of new lines of business and similar transactions but excluding, on a dollar-for-dollar basis, any expenditures made by the Company or any of its subsidiaries, where the source of funds for such expenditure is money raised after the original Subscription Date, directly or indirectly, by the Company or any of its subsidiaries, whether pursuant to the issuance of indebtedness, equity or otherwise by the Company or any of its subsidiaries), the VWAP of a Common Share fails to be greater than $0.74 (as adjusted for share splits, share distributions, recapitalizations or similar events) for the ten consecutive trading day period ended on the trading day immediately preceding such calendar day, then the holders of the Series B Warrants may exercise the Series B Warrants in an Alternative Cashless Exercise. This Alternative Cashless Exercise would permit such Series B Warrant holder to obtain a number of Common Shares equal to 200% of (i) the total number of Common Shares with respect to which the Series B Warrant is then being exercised multiplied by (ii) 0.81, being the initial exercise price of the Series B Warrant (as adjusted for share splits, share distributions, recapitalizations or similar events) divided by (iii) 85% of the quotient of (A) the sum of the VWAP of the Common Share for each of the five lowest trading days during the fifteen trading day period ending on and including the trading day immediately prior to the applicable Exercise Date, divided by (B) five, less (iv) the total number of Common Shares with respect to which the Series B Warrant is then being exercised.
Quelle:
Hier die entscheidende Textpassage zu den B-Warrants:
If, on any calendar day occurring on or after May 26, 2015 (or such earlier date that the Company or any of its subsidiaries, on a consolidated basis, have spent an aggregate of $4 million, in cash or cash equivalents outside of the ordinary course of business after the original Subscription Date, including, without limitation, payments in connection with acquisitions, strategic partnerships, acquisitions of new lines of business and similar transactions but excluding, on a dollar-for-dollar basis, any expenditures made by the Company or any of its subsidiaries, where the source of funds for such expenditure is money raised after the original Subscription Date, directly or indirectly, by the Company or any of its subsidiaries, whether pursuant to the issuance of indebtedness, equity or otherwise by the Company or any of its subsidiaries), the VWAP of a Common Share fails to be greater than $0.74 (as adjusted for share splits, share distributions, recapitalizations or similar events) for the ten consecutive trading day period ended on the trading day immediately preceding such calendar day, then the holders of the Series B Warrants may exercise the Series B Warrants in an Alternative Cashless Exercise. This Alternative Cashless Exercise would permit such Series B Warrant holder to obtain a number of Common Shares equal to 200% of (i) the total number of Common Shares with respect to which the Series B Warrant is then being exercised multiplied by (ii) 0.81, being the initial exercise price of the Series B Warrant (as adjusted for share splits, share distributions, recapitalizations or similar events) divided by (iii) 85% of the quotient of (A) the sum of the VWAP of the Common Share for each of the five lowest trading days during the fifteen trading day period ending on and including the trading day immediately prior to the applicable Exercise Date, divided by (B) five, less (iv) the total number of Common Shares with respect to which the Series B Warrant is then being exercised.
Quelle: